A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer Academic Article uri icon

Overview

MeSH Major

  • Fallopian Tube Diseases
  • Neoplasm, Residual
  • Ovarian Neoplasms
  • Peritoneal Neoplasms
  • Tomography, X-Ray Computed

abstract

  • A prophylactic, extended carboplatin infusion was not associated with a decreased HSR rate. The overall low HSR rate suggests that premedication may help reduce HSRs.

publication date

  • July 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC6033627

Digital Object Identifier (DOI)

  • 10.1097/IGC.0000000000001280

PubMed ID

  • 29757876

Additional Document Info

start page

  • 1176

end page

  • 1182

volume

  • 28

number

  • 6